Organogenesis Holdings Inc. (ORGO) › RevenueOrganogenesis Holdings Inc. (ORGO) — RevenueAnnual figures by fiscal year, from SEC filings.2016: $138.73M2017: $198.51M2018: $193.45M2019: $260.98M2020: $338.30M2021: $467.36M2022: $450.89M2023: $433.14M2024: $482.04M2025: $564.17M$564.17M2016Revenue (USD)2025Fiscal YearRevenueChange YoY2025$564.17M+17.0%2024$482.04M+11.3%2023$433.14M-3.9%2022$450.89M-3.5%2021$467.36M+38.2%2020$338.30M+29.6%2019$260.98M+34.9%2018$193.45M-2.5%2017$198.51M+43.1%2016$138.73M—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share